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8. ABSTRAK 
 
PENGENALAN   
 
Barah payudara di Malaysia merupakan kanser paling kerap menyerang wanita tanpa 
mengira kaum dan berlaku pada peringkat umur lebih muda berbanding pesakit di negara 
maju. Penyebab kematian barah ke empat tertinggi di Malaysia dan pesakit yang dikesan 
berperingkat teruk dengan saiz ketumbuhan besar dan dalam peringkat akhir barah.  
 
Terdapat banyak barah bereseptor-negatif dan bergred histopatologi tinggi di Asia 
berbanding dengan negara-negara maju mengundang persoalan sama ada kewujudan pola 
berlainan pada barah payudara di Asia.  
 
OBJEKTIF KAJIAN 
 
Tujuan kajian adalah menentukan kewujudan hubungan antara umur pesakit dengan status reseptor 
barahnya. Hubungan antara status reseptor barah dengan faktor-faktor prognostik lain seperti saiz 
barah, status kelenjar ketiak, gred barah juga dikaji.     
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TATACARA 
 
Kajian retrospektif melibatkan 160 pesakit didiagnosa dari 1 
 
Januari 2003 hingga 31 
Disember 2008. Senarai nama didapati dari senarai pendaftaran kanser Jabatan Patologi 
Hospital Raja Perempuan Zainab II (HRPZ II) dan Hospital Universiti Sains Malaysia 
(HUSM). Maklumat-maklumat tersebut kemudian didapati dari buku-buku catatan 
perubatan di Unit Rekod dan dianalisa dengan perisian komputer SPSS, versi 12.0. 
 
KEPUTUSAN 
 
Kajian mengenalpasti perhubungan antara saiz barah, kehadiran kelenjar ketiak dengan 
tahap keterukannya. Kebanyakan pesakit berumur di antara 40 hingga 49 tahun. Sedikit 
sahaja yang bersaiz barah 2 cm dan ke bawah semasa didiagnosa. Tahap II dan gred III 
merupakan tahap paling banyak dikesan. Hanya 47.8% ialah ER positif dan 51.5% ialah PR 
positif.  
 
KESIMPULAN 
 
Kajian tidak dapat membuktikan hubungan keterukan barah dengan umur dan status 
reseptornya. Kebanyakan pesakit yang bersaiz barah besar bergred histologi yang tinggi, 
berreseptor negatif dan kelenjar ketiak yang positif barah.  
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9. ABSTRACT 
 
 
In Malaysia, breast cancer is the commonest cancer in all ethnic.  Breast cancer in 
Malaysian women occurs in the younger age group compared with Western countries and 
the fourth most common cause of death among all cancers in Malaysia. Stage at 
presentation here is more advanced with tumor size being much larger and with either 
locally advanced or metastatic breast cancer. There was a higher proportion of hormone 
receptor-negative with higher grade tumour in Asian patients compared to Western 
countries raises questions whether a different pattern of breast cancer is seen in Asian.  
 
OBJECTIVES 
 
The aim of this study is to evaluate the age at presentation and hormone receptor status of 
breast cancers and its association with other established prognostic factors for example 
tumor size, lymph node status and tumour grade.  
  
METHODOLOGY 
 
This is a study of retrospective record review of 160 patients diagnosed from 1st January 
2003 to 31st December 2008. List of name of patients have been obtained from cancer 
registry of Pathology Department in Hospital University Sains of Malaysia (HUSM) and 
Hospital Raja Perempuan Zainab II (HRPZ II). The data were obtained from medical 
 xix 
records. Data were entered into data collection protocol and were analyzed using SPSS 
software version 12.0. 
 
RESULTS 
 
This study identifies the association between tumour size and lymph node involvement and 
staging of breast cancer at presentation.  Majority breast cancer patients in this study were 
from 40 to 49 years old. Minority of patients had tumour size 2cm and below at 
presentation. The commonest stage at presentation of breast cancer was at stage II and 
grade III. Only 47.8% were ER (+) and 51.5% were PR (+) respectively.  
 
CONCLUSION 
 
This study cannot prove of association between young age and receptor status with 
advanced stage of breast cancer. Majority of patients presented with large size tumour with 
poorly differentiated histology, estrogen receptor-negative and lymph node metastases.   
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CHAPTER 1: INTRODUCTION 
 
Breast cancer is the commonest cancer in all ethnic groups and all age groups in 
Malaysian females from the age of 15 years. National Cancer Registry 2004 reports 
breast cancer was the most frequent cancer among females in Peninsular Malaysia 
(31%) followed by cervix uteri cancer (12.9%) and colon cancer (6%) (Lim and Yahya, 
2004).  Furthermore it was the fourth most common cause of death among all cancers in 
Malaysian with ranged from 7.0% to 7.5% (Hisham and Yip, 2003). 
 
Figure 1.1: Example case of locally advanced left breast cancer treated at HRPZ II 
(photograph taken by the author after consented by patient) 
 
In general, breast cancer in Malaysian women occurs in the younger age group with 
peak prevalence between 40 and 49 years of age compared with Western countries 
(between 50- to 59-year-old age group) (Hisham and Yip, 2003). He also reported the 
stage at presentation here is more advanced with tumor size is much larger and with 
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either locally advanced or metastatic breast cancer (Figure 1.1). This was supported by a 
recent report of similar finding by Agarwal et al (2007). He found that the pathology 
and clinical pictures of breast cancers in young Asian women are different from those of 
average patients managed elsewhere in the world. Lim et al (2007) showed a clinico-
pathologic feature of breast cancer in Singaporean women differs from what have been 
observed in the Caucasians.  Patients present here at a younger age, with more advanced 
stage and fewer estrogen-positive tumors. The aggressive behaviour of breast cancer, 
particularly when it occurs in younger women with negative estrogen receptor status, 
raises more questions than answers whether a different pattern of breast cancer is seen 
in Asian. Furthermore most of the studies of breast cancer were done in Western region.  
 
There were a few studies done regarding breast cancer among Malaysian population. 
Hisham et al (2004) reported that only a small number of published data of breast 
cancer on the race, age and stage at presentation in our country. Furthermore, lack of 
national cancer registry in Malaysia cause a difficulty in determining the exact breast 
cancer incidence in Malaysia (Hisham and Yip, 2004).  
 
Kelantan is one of fourteen states in Malaysia federation. It is situated at the north-east 
coast of Peninsular Malaysia. The state is facing the South China Sea and it covers a 
land area of 14,922 sq km. Kelantan has an estimated population of 1.37 million. It is a 
state with a majority Malay ethnic group, comprising ninety five percent of the 
population, followed by Other Bumiputras (2%), Chinese (1.5%) and Indian (1%) of 
population (Kelantan Tourism Information Center 2010). Because of small numbers of 
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non-Malay patients, it would be difficult to analyze these clinical observations 
according to ethnicity; therefore all patients were analyzed as a group. 
 
Hospital Raja Perempuan Zainab II (HRPZ II) and Hospital Universiti Sains Malaysia 
(HUSM) are situated in the center of Kelantan. Both hospitals are the main public 
tertiary referral centres in the state that offers management of breast carcinoma. HRPZ 
II is managed under Ministry of Health and HUSM is under Ministry of Higher 
Education. HUSM usually receive referral cases from districts of Bachok, Pasir Puteh, 
Besut (Terengganu) and occasionally receive referral from Setiu, Terengganu. HUSM is 
the only hospital in Kelantan that offers radiotherapy and oncology services. HRPZ II 
received referral from other district hospitals.  
 
Tumour size, lymph node status, histological grade, mitotic index, estrogen receptor 
(ER), progesterone receptor (PR), c-erbB2, p53 and MIB-1 proliferation index are 
known as prognostic factors used for breast cancer (Aryandono et al., 2006). The 
estrogen and progesterone receptor examination is recommended especially for 
predictor of response to hormonal treatment (Aryandono et al, 2006).  
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The aim of this study is to evaluate the age at presentation and hormone receptor status 
of breast cancers in Kelantan and Besut district of Terengganu and its association with 
selected established prognostic factors. Breast cancers were studied clinically, 
pathologically and immunohistochemically for age at presentation, tumor size, lymph 
node status, estrogen receptor, progesterone receptor. The associations of ER and PR 
with those prognostic factors are determined. 
 
I hope that the result of this study will enrich the literature on various aspect of breast 
carcinoma in our local setting. It also can predict on the progression of patients after the 
primary cancer treatment.  
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2.1 HISTORY OF BREAST CANCER 
 
Breast cancer may be one of the oldest known forms of cancerous tumors in humans. It 
already recorded in document ancient word for more than 5000 years (Sakorafas, 2001). 
The oldest description of cancer was discovered in Egypt stated in The Edwin Smith 
Surgical Papyrus, which probably dates back to the pyramid age of (3000–2500 BC) 
and is believed to contain the first reference to breast cancer.  
 
Herodotus (484–425 BC) claimed a Persian physician living in Greece, cured the wife 
of Persian King Darius of a breast tumor that had ulcerated and spread. Hippocrates 
(460–375 BC) described cases of breast cancer with bloody discharge from nipple and 
he noted that when the discharge stopped, the patient died (Donegan, 2002).  
 
In the Renaissance era, Andreas Vesalius (1514 ± 1564) has treated breast cancer by 
wide local excision (Sakorafas, 2001). Charles Moore (1821–1870) recommended 
removal of axillary nodes and the pectoral muscles if they were involved with breast 
cancer. William M. Banks in Liverpool carried mastectomy by practicing routine 
removal of axillary lymph nodes (Donegan, 2002). Richard von Volkmann and Lothar 
Heidenheim in Germany proposed the removal of the pectoralis major muscle fascia en 
bloc with the breast and the axillary lymph nodes.  
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William Halsted (1852–1922), professor of surgery at Johns Hopkins Hospital in 
Baltimore, USA was aware of it. He started what became known as the radical 
mastectomy. He removed whole breast tissue, the pectoralis major muscle, pectoralis 
minor muscle and the axillary lymphatics.  This procedure became known as the classic 
Halsted radical mastectomy. This result with a dramatic fall in local recurrence to 6% 
compared with the 56–81% reported in Europe (Sakorafas, 2001; Donegan, 2002). 
 
The Halsted radical mastectomy usually causes long-term pain and disability although 
was seen as necessary in order to prevent the cancer from recurring.  In 1948, Patey and 
R. S. Handley in London proposed “conservative” radical mastectomy. They felt that 
removal of the pectoralis major did not add to the value of surgical treatment with 
radical mastectomy. It is also justified to preserve the pectoralis major muscle unless it 
was directly involved by cancer. This operation finally prevails in 1979 as the 
“modified” radical mastectomy by both Hugh Auchincloss Jr. and Madden.  
 
This modified radical mastectomy is further modifed by preserving both the pectoralis 
major and the pectoralis minor muscles (Sakorafas, 2001; Donegan, 2002). This 
procedure become standard surgical treatment of breast cancer in view of  local control 
and survival rates achieved with modified radical mastectomy were comparable to those 
for the Halsted radical mastectomy (Sakorafas, 2001). 
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2.2 BRIEF MANAGEMENT OF BREAST CANCER 
 
Breast cancer is the abnormal growth of cells in the breasts, which leads to the 
development of malignant tumours. Most common origin of breast cancer is from inner 
lining of milk ducts or the lobules that supply the ducts with milk. Cancers originating 
from ducts are known as ductal carcinomas and originating from lobules are known as 
lobular carcinomas.  
 
2.2.1 Triple assessment 
There are increasing rate of breast cancer and most rapid increase are from developing 
countries as the result of ‘westernisation’ of lifestyles (Bray et al 2004). Breast lump is 
the most common presenting symptom to breast clinic. The other symptoms of breast 
cancer are changes in the size of the breast, breast pain, changes on the skin of breast, 
nipple discharge or nipple retraction. Usually patients will review as outpatient setting 
with triple assessment approach. This is an ideal approach for patient with suspicious 
breast lump which assess the clinical, histopathological, and radiological.  
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After detailed history, physical examination, and mammography, patients will undergo 
fine needle aspiration cytology (FNAC) procedure or tru-cut biopsy. FNAC and tru-cut 
biopsy is the diagnostic tool of breast cancer. FNAC is performed by the 
histopathologist while tru-cut biopsy is performed by surgical medical officer or by 
surgeon. Histopathology results will be reviewed by surgical team and discussion 
regarding mode of treatment explained to patients.  
 
FNAC has a sensitivity of 90% and specificity close to 100% (Bdour et al, 2008). It is a 
useful test because it is fast, cheap and less invasive. (Lieske et al, 2006). Unfortunately 
it has percentage of uncertainty and certain surgeons are reluctant to accept FNAC 
reports as basis for ultimate diagnosis because it lack of important information about the 
histopathological type, grade, receptors, and intrinsic behavior of the tumor (Bdour et 
al, 2008). 
 
Tru-cut biopsy is now considered to be the standard in the preoperative assessment of 
breast cancer. In certain place for example in the United Kingdom, tru-cut biopsy has 
largely replaced FNAC (Lieske et al, 2006). It is superior to FNAC in confirming breast 
cancer in suspicious lumps because it is more accurate with the sensitivity of 97%, and 
specificity 100%. It is able to give histological diagnosis and further information about 
tumor type, grade, lymph vascular invasion, and receptors status (Bdour et al, 2008).  
This information is great importance to provide reliable information for preoperative 
evaluation to improve in the pre-surgical decision-making and allows the use of 
preoperative adjuvant therapy (Bdour et al, 2008). 
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Patients diagnosed to have breast cancer will be informed of advantages and 
disadvantages of each treatment and subsequently decided on the definite therapeutic 
treatment. All these information are important for preoperative evaluation by both 
surgeon and oncologist either for neoadjuvant treatment or adjuvant treatment of breast 
cancer. For adjuvant therapy of breast cancer, surgical intervention is the first modalities 
of treatment. Surgical procedures consisted of modified radical mastectomy or breast 
conserving treatment.  
 
2.2.2 Post operative management 
Post operative histopathology report on histological type, histological grade, 
lymphovascular invasion, pathological tumour size, number of lymph node 
involvement, hormonal receptors status (estrogen and progesterone receptors), c-erb B2 
status, resection free margin of breast cancer will be reviewed and patients will be 
further investigated  for staging either by computed tomography scan (CT scan), 
ultrasound or bone scan.  
 
Post operative treatment of breast cancer is based on the post operative histopathology 
report and staging. It is a multidisciplinary treatment and consists of chemotherapy, 
radiotherapy, hormonal therapy, immune therapy and supportive therapy. Standard 
chemotherapy used is combination cyclophosphamide, adriamycin and 5-fluorouracil 
(CAF regime) or cyclophosphamide, methothrexate and 5-fluorouracil (CMF regime). 
For more aggressive tumour, a taxane drug, such as docetaxel, is used for 
chemotherapy.  
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Radiation is usually added to the surgical bed for resection margin involvement of 
breast cancer. Monoclonal antibodies, such as trastuzumab (Herceptin), are used for 
cancer cells that have the HER2 mutation. Breast cancers with positive estrogen 
receptor hormone receptors will be started on selective estrogen receptor modulators 
(SERMs) for example tamoxifen. For patients with presented with locally advanced 
inoperable tumors, neoadjuvant chemotherapy was used for down size of breast cancer 
 
2.3 BRIEF ANATOMY AND PHYSIOLOGY OF BREAST 
 
Breasts or mammary gland are specialized accessory glands of the skin able of 
producing and secreting milk. The shapes are various. At puberty, breast will gradually 
enlarge and assume their hemispherical shape by influence of the ovarian hormones on 
the mammary glands. The ducts elongate and the increase size of the glands is mainly 
from deposition of fat (Snell, 1992). Usually nulliparous women have a hemispherical 
shape, while those of multiparous women are broader and pendulant. In old age, the 
breast volume decreases and it becomes less firm, flatter and pendulant (Macéa, 2006).  
 
Despite individual variation in size and volume, the extent of the base of the breast is 
fairly constant (Sinnatamby, 2001). The base of the breast extends superiorly from the 
level of the second rib to inferiorly as far as the level of the sixth or seventh ribs and 
from the lateral margin of the sternum to the midaxillary line (Snell, 1992).  
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A non-lactating breast weight ranges from 150 to 225g, while a lactating breast may go 
beyond 500g in weight (Macéa, 2006). Each breast consists of 15-20 lobes, which 
spread out from the nipple (Snell, 1992). Strands of fibrous tissue (forming the 
suspensory ligaments of Cooper) attach the dermis of the overlying skin to the ducts of 
the breast. The suspensory ligament of Cooper helps to preserve the protuberance of the 
young breast.  
 
Breast become atrophy and pendulous with increasing age and when contracted by the 
fibrosis associated with certain carcinoma of the breast, they cause dimpling of the 
overlying skin. Malignant involvement of dermal lymphatics will cause pitting of the 
oedematous skin (an appearance often referred to as peau d’ orange) (Sinnatamby, 
2001). The lymphatic drainage of breast is of clinical importance because of spread of 
the malignant cells along the lymph vessels (Snell, 1992). Seventy five percent of the 
lymphatic drainage of the breast passes to axillary lymph nodes, mainly to the anterior 
nodes, even though direct drainage to central or apical nodes is possible.  
 
There are possibilities of direct drainage from the breast to inferior deep cervical 
(supraclavicular) nodes. These minor pathways tend to pass on lymph from the breast 
when the major channels are blocked by malignant disease (Sinnatamby, 2001). 
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Blood supply to the breast is derived mostly from the lateral thoracic artery. The various 
supplying vessels create an anastomosing network. Venous drainage pathway to 
posterior intercostals veins provides an important link to the internal venous plexus 
vertebral veins and hence a pathway for metastatic spread to bone (Sinnatamby, 2001). 
 
Progesterone and estrogen hormones are the important regulators in reproductive 
activity of women. They are ovarian steroid hormones and play a role in the 
development and function of the mammary gland, uterus and the ovary (Gao et al, 
2002). It has been demonstrated that estrogen hormone controls the early ductal 
morphogenesis of the mammary gland, whereas progesterone hormones controls ductal 
branching and alveolar development of the mammary gland during pregnancy (Gao et 
al, 2002 ).  
 
Figure 2.1 Anatomy of left breast (Adapted from Macéa, 2006). 
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2.4 BREAST FEEDING AND HOLY QUR’AN 
 
Breast-feeding has shown to have protective effect against development of breast cancer 
and this protective effect is only valuable after prolonged breast feeding. It is potentially 
adjustable behaviour and represents one of the opportunities for intervention at present. 
There are variation of incidence of breast cancer which is markedly lower among 
populations in which breast-feeding is the most common and the most prolonged 
(Lipworth et al, 2000). Breastfeeding is a normal practice and culture to many Asian 
women. Breastfeeding is related to socio-economic status, educational level, 
employment and marital status of the women.   
 
2.4.1 Breast feeding and Holy Quran 
 
Breast feeding is encouraged by Islamic teaching: In Sura Al-Ahqaf, it is mentioned; 
“the carrying of the (child) to his weaning is (a period) of 30 months”.  In verse 14 of 
Surat Luqman: Quran establish the period of lactation with almost two years. “And We 
enjoined on man concerning his parents- his mother bore him in weakness upon 
weakness, and his weaning was in two years.” (31:14). This similar with agreement 
with modern scientific finding where the maximum period of breast-feeding is two 
years (Khattak et al, 2006).  
 
Al-Sahab et al (2008) studied breastfeeding behaviour among Muslim and Christian 
mothers. He reported that Islamic teaching plays a significant role in continuation of 
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breasfeeding until four months of age with Muslim mothers twice likely to breast-feed 
compare with Christian women. 
 
2.4.2 Risk of cancer 
 
There are several mechanism postulated for association between breast-feeding and 
breast cancer. Unsuckled breasts cause milk has a slightly alkaline composition in 
comparison to that from suckled breasts, which remain acidic during breast-feeding. 
This alkaline environment will cause epithelial cell to undergo preneoplastic alterations, 
such as hyperplasia, cell atypia, and increased mitotic activity at a more frequent rate. 
Cholesterol–b-epoxide level, a potential carcinogen is lower in the breast fluid of 
women during and up to 2 years after breast-feeding (Lipworth et al, 2000). 
 
Lactation causes long-term reduced endogenous estrogen, increased prolactin 
production and reduce exposure to estrogen thus inhibiting the initiation or growth of 
breast cancer cells. Excretion of carcinogenic agents from the breast ductal tissue 
through breast-feeding also been suggested for protective effect of breast cancer 
(Lipworth et al, 2000). 
 
Although the highest prevalence of breastfeeding in Malaysia was in Kelantan but 
unfortunately this traditional habit of reproduction has been abandon due to 
urbanisation. Women have postponed marriages or having children and this 
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reproductive pattern behaviour increasing risk of breast cancer and will increase 
incidence of breast cancer in Malaysia  (Norsa’adah et al., 2005). 
 
2.5 EPIDEMIOLOGY OF BREAST CANCER 
 
All women are at risk of developing breast cancer regardless of their ethnic or country 
of origin. It is considered as the commonest cancer among women worldwide. The rate 
of incidence varies. “Rate” refers to number of breast cancer incidence per 100,000 
woman-years. The incidence rate of breast cancer is low in Far Eastern and South 
Eastern Asian countries; intermediate (around 20) in South America and Southern 
Europe; and the highest (more than 23) in Western Europe and North America (Lacey et 
al, 2002).  
 
A difference in incidence rate among countries indicates the importance of inherent 
genetic risk in breast cancer etiology or may be due to differential access and utilization 
of health care resources such as screening and diagnosis (Lacey et al, 2002). Recently, 
the incidence of breast cancer in developing Asian countries is emerging as the 
commonest female malignancy, overtaking cancer of the uterine cervix (Agarwal et al, 
2007).  
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2.5.1 Breast cancer in Asia 
 
In Asia, breast cancer is the leading cause of cancer-related deaths (Agarwal et al, 
2007). Increasing trend of breast cancer in developing countries is a result of the 
‘westernisation’ of lifestyles such as childbearing, dietary habits and exposure to 
exogenous estrogen, towards of women in industrialised countries. Bray et al (2004) 
reported the comparisons of breast cancer risk in (low-risk) Asian populations migrating 
to the (high-risk) United States of America. It showed that environmental (rather than 
genetic) factors were responsible for most of the observed international and inter-ethnic 
differences in breast cancer incidence. Apart from that, only about fifty five percent of 
breast cancer cases can be explained by identified risk factors despite extensive 
historical and current investigation (Lacey et al, 2002).  
 
2.5.2 Breast cancer in Malaysia 
 
In Malaysia, there was lack of data on incidence of breast cancer until the National 
Cancer Registry (NCR) was started in 2003 (Yip et al, 2006). This current data on 
incidence of cancer only refers to Peninsular Malaysia. There are serious uncertainty 
about cancer registration from Sabah and Sarawak because inadequate reporting of 
cases (Lim and Yahya, 2004). Although the incidence of breast cancer here is lower 
than in the western world, breast cancer is considered as the leading cause of cancer 
death among Malaysian women (Taib et al, 2007).  
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Age standardised incidence rate (ASR) of breast cancer in Malaysia are 46.2 per 
100,000 women.  One in twenty women Malaysian woman will develop breast cancer in 
their lifetime. Statistical incidence of breast cancer in Malaysia in 2003 showed that 
50% of patients were below the age of 50 years, with 40-49 year old as the prevalent 
age group, accounting for more than 30% of the cases (Yip et al, 2006). 
 
2.6 RISK FACTORS FOR BREAST CANCER 
 
Table  2.1 Risk Factors for developing breast cancer (Adapted from Yip et al , 2006)  
 
Increasing age  
Geographic location 
Family history 
Reproductive factors 
Early menarche less than 11 years 
Late menopause more than 55 years 
Nulliparity 
Late first child-birth more than 30 years 
Carcinoma of the uterus 
Carcinoma of the ovary 
Dietary factors – diet rich in animal fats 
Exogenous hormones - Oral contraceptives 
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Table 2.1 (Cont.) 
Hormone replacement therapy 
Alcohol – more than 2 drinks pre day 
Postmenopausal obesity 
Higher socio-economic group 
Limited breast feeding (for long periods is a protective factor) 
 
 
Determining the risk factors in breast cancer will offer hopeful promise of modifying 
those factors. Some of the risk factors of breast cancer can be modified either through 
behavioural or environmental changes (Norsa’adah et al., 2005). Factors that can 
influence the risk of breast cancer are old age, (BRCA1/BRCA2) gene mutations, 
previous diagnosis of atypical ductal or lobular hyperplasia, first-degree relative with a 
breast cancer, longer exposure to endogenous hormones (early menarche, late 
menopause and obesity, or with recent and prolonged use of hormone replacement 
therapy) or with behavioural factors such as high alcohol and fat intake. Risk factors 
related to lifestyle can be changed (Biglia et al, 2004).  
 
Women with BRCA 1 and BRCA 2 mutation carrier have a 37–85% cumulative risk of 
developing breast cancer before 70 years of age. History of atypical ductal or lobular 
hyperplasia is associated with a two to fourfold increase in risk of developing breast 
cancer. Family history of breast cancer is one of important risk factor. Risk of 
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developing breast cancer is increased by two to three times when there is a strong 
family history of breast cancer (Biglia et al 2004). 
 
Long exposure to endogenous hormones as a result of early menarche, late menopause 
and obesity, or with recent and prolonged use of hormone replacement therapy (HRT) 
or with behavioural factors such as high alcohol and high fat intake carries a relative 
risk between one and two (Biglia et al 2004).  
 
The incidence rate of breast cancer of certain races changes among migrants, who rather 
quickly acquire the rates in their host country, indicate that lifestyle factors can 
dramatically affect risk of developing breast cancer (Lacey et al, 2002). Evidence in 
migratory study showed increase incidence of breast cancer of certain races when their 
migrate to countries that their per capita intake of dietary fat is higher (Kamarudin et al, 
2006). Korean migrants living in the United States have substantially higher incidence 
levels of breast cancer than women in their mother country. This finding suggests the 
risk of breast cancer might further increase according to the changes in environmental 
habits (Yoo et al, 2006).  
 
Hormonal concentration are effected by physical activity and exercise, thus they can 
affect the occurrence of diseases especially chronic diseases such as malignancy. 
Estrogen hormone exposure that is secreted by the fat tissue can indirectly be reduced 
by exercise. Exercise can interrupt the menstrual cycle by suppressing the pulsatile 
release of gonadotrophin-releasing hormone. Reducing the fat tissue will indirectly 
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reduce breast exposure to the estrogen hormone. In view of above reason, 
encouragement of healthy lifestyle should be continuous and practiced (Kamarudin et 
al, 2006).   
 
It is important to study the risk factors in breast cancer so that suitable preventive 
measures can be advise (Kamarudin et al, 2006).  Incidence of breast cancer can be 
decrease by the changing in modifiable risk factors such as  hormone replacement 
therapy, alcohol consumption, lack of physical activity and duration of breastfeeding 
(Baquet et al, 2008 ).  Risk of getting breast cancer is increase in certain lifestyle 
(Kamarudin et al, 2006). Study on risk factors in Kelantan showed that the higher risks 
of breast cancer were significantly associated with nulliparity, overweight/obesity, 
family history of breast cancer and oral contraceptive usage (Norsa’adah et al, 2005).  
 
2.7 RACE AND BREAST CANCER 
 
There are variations in breast carcinoma incidence, mortality, and survival among 
multiracial/multiethnic populations. Variations in incidence rates of breast cancer 
among multicultural populations suggest that etiologic factors differ in their biologic 
expression (Hunter, 2000).  
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Breast cancer in African American women is biologically more aggressive, with more 
poorly differentiated tumors, high grade nuclear atypia, and less estrogen receptor 
positivity compared with White women (Hunter, 2000). Breast cancer has a lower 
incidence in Asia than in Europe and North America. There are exceptional countries in 
Asia like Pakistan and the Philippines with relatively high rates, suggesting to major 
differences in the impact of risk or beneficial factors in the region (Moore et al, 2003).  
 
Breast cancer patients among Indonesian, Malaysia and Thailand showed aggressive 
phenotype (Aryandoyo et al, 2006). Depending on racial distribution, the most common 
incidence of breast cancer in Malaysia is Chinese followed by Indian women and then 
Malay women (Taib et al, 2007).  
 
2.8 AGE AND BREAST CANCER 
 
Young age is an indicator of poor prognosis in breast cancer patients (Agarwal et al, 
2007). Majority of breast cancers occur in old age with approximately ⅔ breast cancer 
cases are found after 55 years of age. There are two main breast cancer populations 
according to age at onset. The first type occurs at early-onset with peak incidence near 
age 50 years. The second breast cancer type occurs at late-onset with its mode occurring 
at age 70 years (Anderson et al, 2006).  
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Young breast cancer patients usually presented with more advanced stage disease and 
have more aggressive tumor characteristics (higher grade tumors and more estrogen- 
and progesterone receptor-negative tumors) (Maggard et al 2003). They usually have a 
greater chance of having an endocrine-unresponsive tumor, and they are more likely to 
present with more extensively proliferating and vessel invading disease (Colleoni et al,, 
2002).  
 
There is a difficulty in detecting tumours in the breasts of young women is because of 
the density of the mammary glands and this problem is particularly pronounced among 
pregnant and lactating women (Kroman et al, 2000). Study has showed that very young 
patients less than 35 years old may not benefit from hormone 
 
therapy, even in cases of 
hormone receptor–positive disease (Ahn et al, 2007).  
Ahn et al (2007) reports younger patients with age less than 35 years old showed worse 
prognosis than older patients (age 35 to 50 years). They had the worst prognosis, with a 
1.46-fold increased risk of dying (Kroman et al, 2000). Regardless of tumour size or 
lymph nodes status, young breast cancer patients have a greater probability of death 
than the older patients (Ahn et al, 2007). The poor survival rate seen in young women 
may reflect differences in tumor biology (Chung et al, 1996).  
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2.9 LATERALITY OF BREAST CANCER 
 
Breast cancer is more likely to be diagnosed in the left breast than the right. It was five 
to seven percent more common in the left than in the right breast (Perkins et al, 2004; 
Ekbom et al, 1994). This finding that was generally consistent among age, race, 
ethnicity, gender, stage, and histologic categories but the reasons are still  uncertain 
(Perkins et al, 2004).  
 
Various hypotheses have been proposed but have not been uniformly accepted or 
confirmed (Perkins et al, 2004). Study by Ekbom et al (1994) on a very huge number of 
women breast cancer over a period of 20 years of Swedish Cancer Registry. He made 
conclusion in his study; (i) that the higher frequency of cancer on the left rather than the 
right breast is not limited to invasive disease but also relevant to pre-invasive (in situ) 
cancer; (ii) that a similar laterality pattern for male as for female breast cancer. 
 
2.10 TUMOUR SIZE (TUMOUR DIAMETER) 
 
Tumour size is an important indicator in breast cancer. The importance of tumor size is 
shown in the TNM Staging System. There are several methods to determine tumour size 
either by clinical palpation, breast imaging studies or direct measurement from the 
surgical resection specimen. The pathology measurement is considered to be a gold 
standard in tumour size measurement  (Pritt et al, 2005).  
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Tumour size is based on the maximum tumour dimension although tumour volume is a 
better measurement of an individual’s tumour burden. Maximum tumour dimension is 
easier to assess and more practical to apply than tumour volume. Following surgery, the 
tumour size will be measured in three directions including the longest axis and two 
orthogonal axes and only the longest axis is taken for staging purposes. The 
measurement should be accurate since the difference of a single millimeter will change 
categorical staging classification. This improper classification will alter patient’s 
management (Pritt, et al, 2005). 
 
2.10.1 TNM staging 
 
Based on the greatest dimension, the tumour size will be categorized into T1, T2, T3 
and T4.  Tumour size measures 2 cm or less is T1 lesion. T1 is further subcategorized 
into T1 mic, T1a, T1b, T1c. T1 mic cancer is when there is present of micro invasion 
measuring 0.1 cm or less in the greatest dimension. T1a, T1b, and T1c measure 0.1 to 
0.5 cm, 0.5 to 1 cm, and 1 to 2 cm, respectively. A T2 tumor is more than 2 cm and less 
than 5 cm and T3 is tumors more than 5 cm in the greatest dimension. Tumour of any 
size but has a direct extension to the skin or to the chest wall is classified under T4 
tumour. T4 is further subcategorized into T4a, T4b, T4c and T4d. T4a tumors extend to 
the chest wall, not including the pectoralis muscle. T4b breast cancers show edema, 
including peau d’orange, skin ulceration, or satellite skin nodules in ipsilateral breast 
and T4c tumor is a combination of T4 a and T4b. Inflammatory carcinoma is classified 
as T4d (Whitman et al, 2006).  
 
